logo

For the Inventor, By the Inventor

Harleysville, PA, United States of America

Kimberly Anne Brun

This inventor holds 5 USPTO granted patents. Top assignees: Smithkline Beecham Corporation, Other. Active years: 1999-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kimberly Anne Brun. Retrieved from https://idiyas.com/inventor/kimberly-anne-brun

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5

% Patents Active = 100.0

Average Co-Inventor Count = 3.2

ph-index = 3

Forward Citations = 18(Granted Patents)


Location History:

  • Philadelphia, PA (US) (1999)
  • Harleysville, PA (US) (1999 - 2002)

Company Filing History:

goldMedal4 out of 2,198 
 
Smithkline Beecham Corporation
 patents
silverMedal1 out of 834,513 
Other
 patents

Years Active: 1999-2002

Loading Chart...
5 patents (USPTO):Explore Patents
1. 6365389 - Human protein kinase H2LAU20 (2002-04-02),
2. 6169166 - Polynucleotide and polypeptide sequences encoding rat mdr1b2 and screening methods thereof (2001-01-02),
3. 6025160 - Polynucleotide and polypeptide sequences encoding rat mdr1b2 and (2000-02-15),
4. 6001623 - Human protein kinase H2LAU20 (1999-12-14),
5. 5948669 - Rat cathepsin K polynucleotide and polypeptide sequence (1999-09-07),

Title: The Innovations of Kimberly Anne Brun

Introduction

Kimberly Anne Brun is a notable inventor based in Harleysville, PA (US). She has made significant contributions to the field of biotechnology, particularly in the development of polypeptides and polynucleotides. With a total of 5 patents to her name, her work has implications for both therapeutic and diagnostic applications.

Latest Patents

Among her latest patents is the invention related to the human protein kinase H2LAU20. This patent discloses the H2LAU20 polypeptides and polynucleotides, along with methods for producing these polypeptides through recombinant techniques. Additionally, it outlines methods for utilizing H2LAU20 polypeptides and polynucleotides in therapy and diagnostic assays. Another significant patent involves rat mdr1b2 polypeptides and polynucleotides, detailing methods for producing these polypeptides and screening for compounds that either agonize or antagonize rat mdr1b2. This patent also includes a method for performing a selection screen to discover compounds that do not affect rat mdr1b2.

Career Highlights

Throughout her career, Kimberly has worked with prominent organizations, including SmithKline Beecham Corporation. Her innovative work has positioned her as a key figure in her field, contributing to advancements in biotechnology.

Collaborations

Kimberly has collaborated with notable professionals such as John A. Feild and Richard J. Chenery, enhancing her research and development efforts.

Conclusion

Kimberly Anne Brun's contributions to biotechnology through her patents and collaborations highlight her role as an influential inventor. Her work continues to impact the fields of therapy and diagnostics significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…